BioSpace News Archive

Press Releases

Stryker names Nick Mead Vice President, Investor Relations

March 31, 2026
·
2 min read
Press Releases

Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year

March 31, 2026
·
11 min read
Press Releases

Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer

March 31, 2026
·
6 min read
Press Releases

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

March 31, 2026
·
8 min read
Press Releases

Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology

March 31, 2026
·
12 min read
Press Releases

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease

March 31, 2026
·
6 min read
Press Releases

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

March 31, 2026
·
10 min read
Press Releases

Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results

March 31, 2026
·
9 min read
Press Releases

Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026

March 31, 2026
·
6 min read
Press Releases

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

March 31, 2026
·
5 min read